The Effect of Platform Switching on Single Implants in the Esthetic Zone, Following Flapless Surgery and Early-Loading Protocols

June 23, 2014 updated by: Yung-Ting Hsu, University of Michigan
The impact of platform switching with flapless surgery on early-loaded single-tooth implants on esthetic outcomes.

Study Overview

Detailed Description

Evaluation of clinical, radiographic and microbial outcomes of single implants with platform switching, compared to those with conventional platform.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109-1078
        • Graduate Periodontics, Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients should be at least 18 years old and not currently pregnant
  • Systemically healthy with no medical contraindications to implant surgery
  • Having intact opposite tooth to proposed implant sites
  • The edentulous ridge with minimal ridge deformities.

Exclusion Criteria:

  • unstable medical status or conditions which may compromise wound healing
  • osseous metabolic disorders (e.g., osteoporosis, Paget's disease etc.)
  • uncontrolled dental or periodontal diseases
  • edentulous ridges with the presence of fibrous dysplasia, severe tissue undercut, residual root, as well as insufficient dimensions or volume

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: platform-switched implants
platform-switched implants vs. platform-matched implants
Other Names:
  • Zimmer TSV™, Zimmer Dental Inc., Carlsbad, CA
Active Comparator: platform-matched implants
platform-switched implants vs. platform-matched implants
Other Names:
  • SuperLine™, Dentium Inc., Cypress, CA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
plaque index
Time Frame: crown placement
(Silness and Loe 1964). 0 represented the absence of plaque. 1 was the presence of plaque at gingival margin. 2 was the presence of visible plaque; whereas 3 was recorded if abundant plaque was observed
crown placement
plaque index
Time Frame: post-loading 3 months
(Silness and Loe 1964). 0 represented the absence of plaque. 1 was the presence of plaque at gingival margin. 2 was the presence of visible plaque; whereas 3 was recorded if abundant plaque was observed
post-loading 3 months
plaque index
Time Frame: post-loading 6 months
(Silness and Loe 1964). 0 represented the absence of plaque. 1 was the presence of plaque at gingival margin. 2 was the presence of visible plaque; whereas 3 was recorded if abundant plaque was observed
post-loading 6 months
plaque index
Time Frame: post-loading 12 months
(Silness and Loe 1964). 0 represented the absence of plaque. 1 was the presence of plaque at gingival margin. 2 was the presence of visible plaque; whereas 3 was recorded if abundant plaque was observed
post-loading 12 months
gingival index
Time Frame: crown placement
(Loe 1967) As for GI, normal gingival was scored as 0. 1 meant the presence of mild inflammation, slight change in color, slight edema and no BOP. Moderate inflammation was represented by 2, inclusive of the presence of gingival redness, edema, glazing and BOP. Severe inflammation with marked redness, edema, ulceration and spontaneous bleeding was scaled as 3
crown placement
gingival index
Time Frame: post-loading 3 months
As for GI, normal gingival was scored as 0. 1 meant the presence of mild inflammation, slight change in color, slight edema and no BOP. Moderate inflammation was represented by 2, inclusive of the presence of gingival redness, edema, glazing and BOP. Severe inflammation with marked redness, edema, ulceration and spontaneous bleeding was scaled as 3
post-loading 3 months
gingival index
Time Frame: post-loading 6 months
As for GI, normal gingival was scored as 0. 1 meant the presence of mild inflammation, slight change in color, slight edema and no BOP. Moderate inflammation was represented by 2, inclusive of the presence of gingival redness, edema, glazing and BOP. Severe inflammation with marked redness, edema, ulceration and spontaneous bleeding was scaled as 3
post-loading 6 months
gingival index
Time Frame: post-loading 12 months
As for GI, normal gingival was scored as 0. 1 meant the presence of mild inflammation, slight change in color, slight edema and no BOP. Moderate inflammation was represented by 2, inclusive of the presence of gingival redness, edema, glazing and BOP. Severe inflammation with marked redness, edema, ulceration and spontaneous bleeding was scaled as 3
post-loading 12 months
Papillary index
Time Frame: crown placement
(Jemt 1997) 0 = the absence of papilla, 1= <50% of the height of the gingival embrasure, 2= 50-99% of the height of the gingival embrasure, 3 = 100% of the proximal space, 4= overgrowth of the interproximal tissue
crown placement
Papillary index
Time Frame: post-loading 3 months
(Jemt 1997) 0 = the absence of papilla, 1= <50% of the height of the gingival embrasure, 2= 50-99% of the height of the gingival embrasure, 3 = 100% of the proximal space, 4= overgrowth of the interproximal tissue
post-loading 3 months
Papillary index
Time Frame: post-loading 6 months
(Jemt 1997) 0 = the absence of papilla, 1= <50% of the height of the gingival embrasure, 2= 50-99% of the height of the gingival embrasure, 3 = 100% of the proximal space, 4= overgrowth of the interproximal tissue
post-loading 6 months
Papillary index
Time Frame: post-loading 12 months
(Jemt 1997) 0 = the absence of papilla, 1= <50% of the height of the gingival embrasure, 2= 50-99% of the height of the gingival embrasure, 3 = 100% of the proximal space, 4= overgrowth of the interproximal tissue
post-loading 12 months
The width of keratinized mucosa
Time Frame: crown placement
measured at the midpoint on mid-facial surfaces of implants and adjacent two teeth.
crown placement
The width of keratinized mucosa
Time Frame: post-loading 3 months
measured at the midpoint on mid-facial surfaces of implants and adjacent two teeth.
post-loading 3 months
The width of keratinized mucosa
Time Frame: post-loading 6 months
measured at the midpoint on mid-facial surfaces of implants and adjacent two teeth.
post-loading 6 months
The width of keratinized mucosa
Time Frame: post-loading 12 months
measured at the midpoint on mid-facial surfaces of implants and adjacent two teeth.
post-loading 12 months
Soft tissue level
Time Frame: crown placement
the vertical distance from the gingival margin to the line connecting the facial gingival margin of two adjacent teeth
crown placement
Soft tissue level
Time Frame: post-loading 3 months
the vertical distance from the gingival margin to the line connecting the facial gingival margin of two adjacent teeth
post-loading 3 months
Soft tissue level
Time Frame: post-loading 6 months
the vertical distance from the gingival margin to the line connecting the facial gingival margin of two adjacent teeth
post-loading 6 months
Soft tissue level
Time Frame: post-loading 12 months
the vertical distance from the gingival margin to the line connecting the facial gingival margin of two adjacent teeth
post-loading 12 months
Probing depth
Time Frame: crown placement
Probing depth (PD) on the implant has also been recorded at 6 points mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual line-angles
crown placement
Probing depth
Time Frame: post-loading 3 months
Probing depth (PD) on the implant has also been recorded at 6 points mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual line-angles
post-loading 3 months
Probing depth
Time Frame: post-loading 6 months
Probing depth (PD) on the implant has also been recorded at 6 points mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual line-angles
post-loading 6 months
Probing depth
Time Frame: post-loading 12 months
Probing depth (PD) on the implant has also been recorded at 6 points mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual line-angles
post-loading 12 months
marginal bone level changes
Time Frame: post-operative 2 weeks, immediately after crown delivery, 3, 6, and 12 months post-loading
the vertical distance between alveolar crest to platform level (both mesial and distal)
post-operative 2 weeks, immediately after crown delivery, 3, 6, and 12 months post-loading
ridge height
Time Frame: prior to surgery
the distance from the highest point of alveolar crest to the base of the maxillary arch
prior to surgery
ridge height
Time Frame: post-loading 12 months
the distance from the highest point of alveolar crest to the base of the maxillary arch
post-loading 12 months
ridge width 3mm below crest
Time Frame: prior to surgery
the distance between the most prominent point on labial and palatal surfaces at the level of 3mm below the crest
prior to surgery
ridge width 3mm below crest
Time Frame: post-loading 12 months
the distance between the most prominent point on labial and palatal surfaces at the level of 3mm below the crest
post-loading 12 months
ridge width 10 mm below crest
Time Frame: prior to surgery
the distance between the most prominent point on labial and palatal surfaces at the level of 10 mm below the crest
prior to surgery
ridge width 10 mm below crest
Time Frame: post-loading 12 months
the distance between the most prominent point on labial and palatal surfaces at the level of 10 mm below the crest
post-loading 12 months
the presence of perforation or dehiscence
Time Frame: post-loading 1 year
using CBCT scan
post-loading 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post-op experience
Time Frame: post-op 2weeks
pain, bleeding, swelling and overall discomfort
post-op 2weeks
microbial analysis
Time Frame: 12 months after loading
peri-implant microbial profile
12 months after loading
post-loading experience
Time Frame: post-op 12 months
comfort, function (chewing/speaking), esthetics, and overall satisfaction
post-op 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2011

Primary Completion (Actual)

March 1, 2014

Study Completion (Actual)

March 1, 2014

Study Registration Dates

First Submitted

June 19, 2014

First Submitted That Met QC Criteria

June 23, 2014

First Posted (Estimate)

June 24, 2014

Study Record Updates

Last Update Posted (Estimate)

June 24, 2014

Last Update Submitted That Met QC Criteria

June 23, 2014

Last Verified

June 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on the Impact of Platform-switching

Clinical Trials on platform-matched implant

3
Subscribe